Reports (55)

  • Health Science
    Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Health Science
    Ingested Nitrate and Nitrite, and Cyanobacterial Peptide Toxins.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Health Science
    MYCOTOXIN CONTROL IN LOW- AND MIDDLE-INCOME COUNTRIES.

    Christopher P. Wild, ?J. David Miller, ?John D. Groopman

    Get Access
  • Health Science
    Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Health Science
    Surgical Implants and Other Foreign Bodies.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Health Science
    Some Drugs and Herbal Products.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Health Science
    Betel-quid and Areca-nut Chewing and Some Areca-nut-derived Nitrosamines.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Health Science
    Some Organic Solvents, Resin Monomers and Related Compounds, Pigments and Occupational Exposures in Paint Manufacture and Painting.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Health Science
    Some chemicals that cause tumours of the urinary tract in rodents.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Contraindications, Drug Contamination, Health Policy, Immunization, Poliovirus Vaccines , United States, Vaccination,
    Biological Agents.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Antibodies, Monoclonal, isolation & purification , Drug Industry, Technology, Pharmaceutical, methods, United States, Vaccines, chemical synthesis, Vaccines, isolation & purification,
    Personal Habits and Indoor Combustions.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Antiviral Agents, therapeutic use, Hepatitis B, drug therapy, Hepatitis B, prevention & control , Hepatitis C, drug therapy, Hepatitis C, prevention & control, United States, Viral Hepatitis Vaccines, therapeutic use,
    Pharmaceutical Drugs.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Adverse Drug Reaction Reporting Systems, Drug Interactions, Hazardous Substances, Military Personnel, United States, Vaccines
    Pharmaceuticals.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Hepatitis B, complications , Hepatitis B, prevention & control , Hepatitis C, complications, Hepatitis C, prevention & control, Liver Neoplasms, prevention & control, United States, Viral Hepatitis Vaccines, therapeutic use,
    Radiation.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Autistic Disorder, etiology, Immunization, Measles-Mumps-Rubella Vaccine, adverse effects , Safety,
    Some Thyrotropic Agents.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Clinical Trials as Topic, Insurance, Health, Reimbursement, Medicare , United States,
    Beryllium, Cadmium, Mercury, and Exposures in the Glass Manufacturing Industry.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Clinical Trials as Topic standards, Health Policy, Neoplasms therapy, Patient Care standards, United States
    Chromium, Nickel and Welding.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Clinical Trials as Topic, Communication Barriers, Ethnic Groups, Healthcare Disparities, Minority Groups, Patient Selection, United States, Women
    Cobalt in Hard Metals and Cobalt Sulfate, Gallium Arsenide, Indium Phosphide and Vanadium Pentoxide.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Clinical Trials as Topic, ethics, Drug Approval, Drug Evaluation, ethics , Product Surveillance, Postmarketing, methods, United States,
    Diesel and Gasoline Engine Exhausts and Some Nitroarenes.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Adolescent, Child, Clinical Trials as Topic legislation & jurisprudence, Clinical Trials as Topic standards, Drug Approval legislation & jurisprudence, Drug Evaluation legislation & jurisprudence, Drug Industry legislation & jurisprudence,
    Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus, Human Herpesvirus 8.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Access to Information, Clinical Trials as Topic , Information Dissemination, International Cooperation, Pharmaceutical Preparations ,
    Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-ol.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Behavioral Sciences, Brain , Clinical Medicine, Research Support as Topic, Social Medicine, United States,
    Hepatitis Viruses.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Clinical Trials as Topic, standards , Decision Making, Quality Control, Research Design,
    Hormonal Contraception and Post-menopausal Hormonal Therapy.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Clinical Trials as Topic, standards, Ethics, Research, Human Experimentation, standards , Neoplasms, Patient Rights, Research Subjects, United States,
    Human Immunodeficiency Viruses and Human T-Cell Lymphotropic Viruses.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Clinical Laboratory Techniques economics, Medicare economics, Prospective Payment System, United States
    Human Papillomaviruses.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Clinical Protocols, Human Experimentation, Patient Rights, Safety
    Inorganic and Organic Lead Compounds.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Clinical Trials as Topic, Information Dissemination
    Ionizing Radiation, Part 1: X- and Gamma Radiation, and Neutrons.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Genetics, Medical , Health Policy, Risk Factors, United States,
    Ionizing Radiation, Part 2: Some Internally Deposited Radionuclides.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Diffusion of Innovation, Evidence-Based Medicine, Genetics, Medical, Genomics , Medical Informatics, United States,
    Man-made Vitreous Fibres.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access
  • Diagnosis, Differential, Genetic Testing , Genetics, Medical, Genomics, Precision Medicine,
    Occupational Exposures in Insecticide Application, and Some Pesticides.

    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

    Get Access

Your Feedback